Pharmaceuticals

AstraZeneca completes equity investment and research collaboration with Cellectis

bexib
By bexib 0 Min Read

The joint venture aims to develop up to 10 new cell and gene therapy products targeting areas of high unmet medical need.

You Might Also Like

Pharmaceutical Executive: June 2024 issue (PDF)

Melissa Krebs Shares Gersana’s Vision for Innovative Wound Care Solutions

FDA approves two Scientia Vascular neurovascular catheters

Johnson & Johnson MedTech Introduces Velys Active Robotic-Assisted System for Planning and Instrumentation in Spinal Fusion Surgery

Healthcare marketing strategies to reach diverse audiences

Share This Article
Previous Article 13 Website Usability Testing Tools
Next Article Exactly steel! Grab your freedom! Domestic product! The name of the horse running in the 2024 Kentucky Derby is correct.
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

Remembering Maker Faires in 2024?
Manufacturing
Top 5 Open Banking Stories of 2024
Banking
Ecommerce SEO Pros on AI, Strategies for 2025
Retail & E-commerce
Brintons launches first commercial carpet collection with V&A
Hospitality & Tourism